global benign prostatic hyperplasia devices market 2015-2019
TRANSCRIPT
USA – CANADA – UK – CHINA – INDIA
Global Benign Prostatic Hyperplasia Devices Market 2015-2019
The report discusses the following in-depth:
• Market Size and Forecast
• Market Segmentation
• Buying Criteria
• Vendor Landscape
• Business Segmentation
• Geographical Segmentation
For more information on the
Global Benign Prostatic Hyperplasia Devices Market 2015-2019please mail us at
USA – CANADA – UK – CHINA – INDIA
Key Trends
Technavio’s Senior Analyst says, “The growing elderly population is a major contributor to the growth of the market. The World Health Organization estimates that about two billion people will be aged 60 and above by 2050. As individuals age, they become susceptible to urological disorders such as benign prostatic hyperplasia. The increased use of MI procedures also propels the growth of the market.”
• Benign prostatic hyperplasia is a condition characterized by noncancerous proliferation of prostate gland cells. This causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. It is associated with aging, hormone imbalances, and abnormal cell growth. Benign prostatic hyperplasia devices are used to perform invasive and MI surgeries to remedy a blocked urethra.
• Technavio's analysts forecast the global benign prostatic hyperplasia devices market to grow at a CAGR of 5.05% percent over the period 2014-2019.
• Understanding the key drivers influencing the market
• Understanding the challenges faced by the market
• Activities of various stakeholders involved
• Key focus areas for the vendors
• Major trends that will shape the future of this market
• Vendor landscape and trajectory of the market
• Conclusion
Scope of The Report
A detailed analysis of each market driver, challenge
and trend isavailable in our report:
Global Benign Prostatic Hyperplasia Devices Market 2015-2019
USA – CANADA – UK – CHINA – INDIA
USA – CANADA – UK – CHINA – INDIA
Vendors
To understand the vendor landscape and for a full list of vendors view our report:
Global Benign Prostatic Hyperplasia Devices Market 2015-2019
Endo International
Karl Storz
Lumenis
Endo International was established in 1997 and is headquartered in Dublin, Ireland. It was formerly known as Endo Pharmaceuticals. The company focuses on the R&D, manufacturing, and marketing of branded and generic pharmaceuticals worldwide.
Karl Storz is a medical devices manufacturing company headquartered in Tuttlingen, Germany. It designs, develops, manufactures, markets, and distributes endoscopic equipment in over 38 countries. It provides medical devices used in neuro-endoscopy, anesthesia and emergency medicine, gastroenterology, gynecology, and urology.
Lumenis was founded in 1991 and is headquartered in Yokneam, Israel. It is a global leader in providing energy-based clinical solutions. The company operates through three segments: the surgical business, aesthetic business, and ophthalmology business.
USA – CANADA – UK – CHINA – INDIA
Market Landscape
• The global benign prostatic hyperplasia devices market is expected to grow steadily because of the growing elderly population, advances in treatment options, and incorporation of novel technologies.
• The market has progressed in developed countries and has immense growth potential in emerging countries such as China, India, Indonesia, Thailand, and other Asian countries.
• The incidence of benign prostatic hyperplasia is high among men aged 60 and above.
• Currently, people with the condition prefer MI procedures over open surgical procedures.
• This factor has increased the number of outpatient procedures performed in hospitals.
• Favorable reimbursement scenarios in developed countries such as the US have also resulted in the increased use of invasive and MI procedures to treat the condition.
USA – CANADA – UK – CHINA – INDIA
Key Buying CriteriaGuest Bloggers
• Authenticity • Delivery • Price• Service
Support
Parameter Details
Cost Devices and accessories used to treat benign prostatic hyperplasia should be reasonably priced.
QualityDevices and systems used to treat benign prostatic hyperplasia should be of high quality and must have authentic therapeutic value.
Safety Devices used to treat benign prostatic hyperplasia should have fewer adverse effects.
Reliability Devices used to treat benign prostatic hyperplasia should be reliable.
• Growth Forecasts?
• Market Analysis?
• Revenue Forecasts?
• Regional and Country level Analysis?
• Competitive Structure?
• Emerging Trends?
• Vendor Landscape?
• Other?
What Would You Like to Learn From Technavio?
Global Benign Prostatic Hyperplasia Devices Market
2015-2019
Let us identify your needs.We would love to hear more!
USA – CANADA – UK – CHINA – INDIA
Our Report Covers: Market Scenarios, Vendor landscape & Industry Road Maps.
You have the Option to Customize Reports & Access Analysts on every Report Purchase.
Purchasing this report?
For media enquiries,please drop us a mail at
We’ll include an hour with our analysts to discuss the report findings.
For free.
USA – CANADA – UK – CHINA – INDIA
Access the Report
USA – CANADA – UK – CHINA – INDIA
India: An Overview
USA – CANADA – UK – CHINA – INDIA
About Us
USA – CANADA – UK – CHINA – INDIA
Thank You!
North America
Chicago, USA
Phone: +1 630 333 9501
Fax: +1 630 833 2171
Europe
London, United Kingdom
Phone: +44 208 123 1770
Fax: +44 845 280 2825
Asia
Bangalore, India
Phone: +91 934 254 0560
Fax: +91 80 4080 6070
DISCLAIMER
This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall
Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.
Copyright ©2013 Infiniti Research Limited. All Rights Reserved.
Reproduction without written permission is completely forbidden.
NOT FOR FURTHER DISTRIBUTION